Enzymatic degradation of collagen as a factor enhancing calcification of epoxy-treated bioprosthetic heart valves: in vitro modeling data
https://doi.org/10.18699/SSMJ20250313
Abstract
Aim of the study was to assess in vitro the impact of enzymatic degradation of collagen on the subsequent calcification of the epoxy-treated bovine pericardium used in the production of bioprosthetic heart valves.
Material and methods. The study involved epoxy-treated bovine pericardium patches, samples of which were incubated with bacterial collagenase solution. The degree of degradation of the samples after enzyme treatment was analyzed by mass loss and changes in mechanical properties. The samples were also subjected to proteolysis, and then placed in a calcification solution for 3 weeks. The calcium content was evaluated by spectrophotometry. The control group included epoxy-treated bovine pericardium patches that were not incubated with bacterial collagenase solution.
Results and discussion. On average, the mass loss of studied samples was equal to 8 % during 24-hour incubation in collagenase, which is comparable to the values for glutaraldehyde-treated pericardium according to the literature data. Moreover, the enzyme treatment led to a decrease in the tensile strength of the studied material (14.15 [13.08–16.58; 11.4–22.43] MPa (median [25th percentile – 75th percentile; minimum – maximum]) in control group vs. 10.67 [7.37–11.6; 6.39–11.95] MPa in the study group, p = 0.0003) and increase in its calcification by 1.6 times (8.61 [6.58–9.81; 4.78–14.53] mg of calcium/g of tissue in the control group vs. 13.41 [10.58–17.27; 7.76–28.41] mg of calcium/g of tissue in the study group, p = 0.0001).
Conclusions. The enzymatic degradation of collagen in the epoxy-treated bovine pericardium enhances its calcification in vitro. The data obtained suggest that the accumulation of collagenolytic enzymes in the leaflets of xenopericardial bioprosthetic heart valves is an important mechanism of structural degeneration.
Keywords
About the Authors
A. E. KostyuninRussian Federation
Alexandr E. Kostyunin, candidate of biological sciences
650002; Academician Barbarash blvd., 6; Kemerovo
T. V. Glushkova
Russian Federation
Tatyana V. Glushkova, candidate of biological sciences
650002; Academician Barbarash blvd., 6; Kemerovo
T. N. Akentyeva
Russian Federation
Tatyana N. Akentyeva
650002; Academician Barbarash blvd., 6; Kemerovo
N. N. Borisova
Russian Federation
Natalya N. Borisova
650002; Academician Barbarash blvd., 6; Kemerovo
K. Yu. Klyshnikov
Russian Federation
Kirill Yu. Klyshnikov, candidate of medical sciences
650002; Academician Barbarash blvd., 6; Kemerovo
P. S. Onishchenko
Russian Federation
Pavel S. Onishchenko
650002; Academician Barbarash blvd., 6; Kemerovo
A. A. Klyueva
Russian Federation
Anastasia A. Klyueva
650002; Academician Barbarash blvd., 6; Kemerovo
E. A. Ovcharenko
Russian Federation
Evgeniy A. Ovcharenko, candidate of technical sciences
650002; Academician Barbarash blvd., 6; Kemerovo
References
1. Barbarash L., Rutkovskaya N., Barbarash O., Odarenko Y., Stasev A., Uchasova E. Prosthetic heart valve selection in women of childbearing age with acquired heart disease: a case report. J. Med. Case Rep. 2016;10:51. doi: 10.1186/s13256-016-0821-y
2. Cote N., Pibarot P., Clavel M.A. Incidence, risk factors, clinical impact, and management of bioprosthesis structural valve degeneration. Curr. Opin. Cardiol. 2017;32(2):123–129. doi: 10.1097/HCO.0000000000000372
3. Marro M., Kossar A.P., Xue Y., Frasca A., Levy R.J., Ferrari G. Noncalcific mechanisms of bioprosthetic structural valve degeneration. J. Am. Heart Assoc. 2021;10(3):e018921. doi: 10.1161/JAHA.120.018921
4. Kostyunin A.E., Glushkova T.V., Lobov A.A., Ovcharenko E.A., Zainullina B.R., Bogdanov L.A., Shishkova D.K., Markova V.E., Asanov M.A., Mukhamadiyarov R.A., … Kutikhin A.G. Proteolytic degradation is a major contributor to bioprosthetic heart valve failure. J. Am. Heart Assoc. 2023;12(1):e028215. doi: 10.1161/JAHA.122.028215
5. Shetty R., Pibarot P., Audet A., Janvier R., Dagenais F., Perron J., Couture C., Voisine P., Després J.P., Mathieu P. Lipid-mediated inflammation and degeneration of bioprosthetic heart valves. Eur. J. Clin. Invest. 2009;39(6):471–480. doi: 10.1111/j.1365-2362.2009.02132.x
6. Zhuravleva I.Yu, Karpova E.V., Oparina L.A., Poveschenko O.V., Surovtseva M.A., Titov A.T., Ksenofontov A.L., Vasilieva M.B., Kuznetsova E.V., Bogachev-Prokophiev A.V., Trofimov B.A. Cross-linking method using pentaepoxide for improving bovine and porcine bioprosthetic pericardia: a multiparametric assessment study. Mater. Sci. Eng. C. Mater. Biol. Appl. 2021;118:111473. doi: 10.1016/j.msec.2020.111473
7. Christian A.J., Lin H., Alferiev I.S., Connolly J.M., Ferrari G., Hazen S.L., Ischiropoulos H., Levy R.J. The susceptibility of bioprosthetic heart valve leaflets to oxidation. Biomaterials. 2014;35(7):2097–2102. doi: 10.1016/j.biomaterials.2013.11.045
8. Sung H.W., Chen W.Y., Tsai C.C., Hsu H.L. In vitro study of enzymatic degradation of biological tissues fixed by glutaraldehyde or epoxy compound. J. Biomater. Sci. Polym. Ed. 1997;8(8):587–600. doi: 10.1163/156856297x00191
9. Ovcharenko E.A., Klyshnikov K.U., Glushkova Т.V., Batranin А.V., Rezvova М.А., Kudryavtseva Y.А., Barbarash L.S. Evaluation of a failed heart valve bioprosthesis using microcomputed tomography. Sovremennyye tekhnologii v meditsine = Modern Technologies in Medicine. 2017;9(3):15–22. doi: 10.17691/stm2017.9.3.02